Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Br J Dermatol ; 158(3): 607-10, 2008 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-18076707

RESUMO

Nephrogenic systemic fibrosis (NSF) describes a characteristic fibrosing disorder which typically presents with indurated plaques on the trunk and extremities of patients with advanced renal disease. We present a case of biopsy-confirmed NSF in a patient with severe acute kidney injury with no prior history of renal disease. A 64-year-old man with an acute and severe decrease in glomerular filtration rate underwent magnetic resonance imaging studies with gadolinium contrast (Omniscan) and subsequently developed NSF. His renal disease had normalized at the time his skin disease developed. Skin biopsies revealed findings of NSF and scanning electron microscopy with energy-dispersive X-ray spectroscopy confirmed insoluble gadolinium within lesional tissue.


Assuntos
Meios de Contraste/efeitos adversos , Gadolínio/efeitos adversos , Nefropatias/complicações , Rim/patologia , Dermatopatias/induzido quimicamente , Fibrose , Taxa de Filtração Glomerular , Humanos , Nefropatias/patologia , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Pele/efeitos da radiação , Resultado do Tratamento
2.
Am J Med ; 91(5): 462-70, 1991 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-1951408

RESUMO

PURPOSE: Oral ciprofloxacin has the requisite pharmacokinetic and antibacterial properties to rival the potency of intravenous antibiotics. This study was designed to determine whether oral ciprofloxacin could abbreviate the course of intravenous antibiotics in the treatment of serious infections. PATIENTS AND METHODS: Hospitalized adult patients were eligible for enrollment if they had a serious infection that was expected to require 8 or more days of intravenous antibiotic treatment. After conventional intravenous antibiotics were administered for 3 days, informed consent was obtained and patients were randomly assigned to either continue parenteral antibiotics (n = 53) or switch to oral ciprofloxacin 750 mg taken twice daily (n = 52). Ninety-nine of the 105 patients were evaluable for the assessment of efficacy. Clinical and bacteriologic efficacy, adverse events, and costs of the two treatments were compared. RESULTS: The two treatment groups were comparable for demographic characteristics, types of infections, bacteria isolated, initial intravenous antibiotic regimens, and duration of antibiotic treatment. The most common infections were of the skin and skin structure; bacteremia and infections of the lower respiratory tract, urinary tract, and bone and joint were also represented. The most commonly isolated pathogens were Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli. The most frequently prescribed intravenous antibiotics before randomization included aminoglycosides, cephalosporins, vancomycin, and nafcillin; 52 evaluable patients were treated with combination therapy while 47 received monotherapy. The clinical and bacteriologic outcomes and adverse reaction frequency with oral ciprofloxacin were comparable to those of the continued intravenous antibiotic regimens. Ciprofloxacin was associated with an average cost savings of $293 per patient. CONCLUSION: When used after 3 days of intravenous antibiotics, oral ciprofloxacin was as safe and effective as full courses of intravenous antibiotics and provided substantial cost savings.


Assuntos
Infecções Bacterianas/tratamento farmacológico , Ciprofloxacina/uso terapêutico , Administração Oral , Adulto , Antibacterianos/uso terapêutico , Infecções Bacterianas/microbiologia , Ciprofloxacina/sangue , Ciprofloxacina/economia , Custos e Análise de Custo , Humanos , Infusões Intravenosas , Cooperação do Paciente , Estatística como Assunto , Resultado do Tratamento
3.
Cancer ; 39(4): 1752-7, 1977 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-851952

RESUMO

Malignant histiocytosis (MH) is a rapidly fatal systemic disease for which there is no adequate therapy. A case of MH with involvement of both eyes resulting in bilateral blindness is presented. Infiltration with malignant cells was seen in the ciliary bodies at autopsy. Attempts at treatment for this complication are discussed.


Assuntos
Cegueira/etiologia , Doenças Linfáticas/complicações , Adulto , Medula Óssea/patologia , Líquido Cefalorraquidiano/citologia , Corpo Ciliar/patologia , Neoplasias Oculares/patologia , Histiócitos/patologia , Humanos , Contagem de Leucócitos , Linfonodos/patologia , Doenças Linfáticas/patologia , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA